Stay updated on Vemurafenib Combo in High-Risk Melanoma Clinical Trial

Sign up to get notified when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new revision entry v3.5.5 was added to the record history, and the previous v3.5.4 entry was removed. This updates the page's version trail.
    Difference
    0.1%
    Check dated 2026-06-06T20:28:17.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.5.4 was added to the page's history and the previous entry v3.5.3 was removed.
    Difference
    0.1%
    Check dated 2026-05-16T09:15:47.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Updated the study record to Completed with Results Posted, including Adverse Events, Outcome Measures (Results), Participant Flow, and Recruitment/Study Status. The previous Active, not recruiting and Results Submitted entries were removed, reflecting the trial's completion and public availability of final data.
    Difference
    0.8%
    Check dated 2026-05-09T11:17:51.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page’s footer/interface version was updated from **Revision: v3.5.2** to **Revision: v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T22:25:45.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T14:19:01.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The latest version adds multiple study-record sections (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Study Design, Study Status) and marks 'Returned' on 2026-04-07, with Quality Control status noted as not concluded.
    Difference
    0.9%
    Check dated 2026-04-10T09:13:13.000Z thumbnail image

Stay in the know with updates to Vemurafenib Combo in High-Risk Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.